Condition
Atrial Fibrillation (Paroxysmal) clinical trials and research
As of November 12, 2026, Find a Trial lists 15 Atrial Fibrillation (Paroxysmal) clinical trials that are recruiting, at sites in 11 countries (most in United States (4), Czechia (3), Italy (2)). 1 was first registered in the last 30 days. By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 15Clinical trials
- 1New in 30 days
- 11Countries
Newest Atrial Fibrillation (Paroxysmal) clinical trials
All recruiting trials (15)
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Biofeedback helps people with paroxysmal atrial fibrillation stay active
This study tests a biofeedback approach using a smartwatch to monitor AF and activity and sends personalized nudges to see if it helps people with paroxysmal AF be more physically active.
-
Progressive Resistance Training First to Help AF and HFpEF Patients Feel Better
This trial tests whether starting with progressive resistance training before aerobic exercise can improve exercise capacity and quality of life in people aged 60 and older who have atrial fibrillation and HFpEF.
-
Digital MediYoga for quality of life and heart measures in paroxysmal atrial fibrillation
This trial will test whether a 12-week, app-delivered MediYoga program can improve disease-specific quality of life and reduce blood pressure and heart rate in adults with paroxysmal atrial fibrillation.
-
Pulsed-field pulmonary vein isolation with optional radiofrequency nerve-targeting for paroxysmal atrial fibrillation
This trial tests whether adding selective radiofrequency ablation of a parasympathetic ganglion to pulsed-field pulmonary vein isolation helps adults with paroxysmal atrial fibrillation have fewer recurrences and fewer bradyarrhythmic events.
-
nano-second pulsed field (nsPFA) catheter ablation for paroxysmal atrial fibrillation using the CellFX system
The study will try the CellFX nano-second pulsed field catheter to treat adults with recurrent, drug-resistant paroxysmal atrial fibrillation.
-
Using a new balloon technique to treat atrial fibrillation
This study is testing a new balloon technique to see if it can safely and effectively treat people with a type of irregular heartbeat called atrial fibrillation.
-
Effects of Alcohol Consumption on Atrial Fibrillation Episodes
This study is testing whether drinking small to moderate amounts of alcohol affects how often people with paroxysmal atrial fibrillation have episodes of irregular heartbeats.
-
Comparing two cryoablation techniques for treating atrial fibrillation
This study is testing whether a larger cryoablation technique can help people with atrial fibrillation have fewer heart rhythm problems after treatment compared to a smaller technique.
-
Using a new catheter system to treat atrial fibrillation
This study is testing a new catheter system to see if it safely helps people with paroxysmal atrial fibrillation feel better after treatment.
-
Comparing pulse field ablation and cryoablation for atrial fibrillation treatment
This study is testing whether a new method called pulse field ablation works better than the traditional cryoablation for treating atrial fibrillation and keeping the heart's function healthy.
-
Assessing esophageal temperature during atrial fibrillation ablation
This study is testing if a new high-power ablation method can keep the esophagus cooler and reduce injury risk during heart procedures for people with atrial fibrillation.
-
Flecainide versus amiodarone for cardioversion of recent paroxysmal atrial fibrillation in patients with treated coronary artery disease
This study will test whether intravenous flecainide works faster and is as safe as intravenous amiodarone to restore normal rhythm in adults with recent paroxysmal atrial fibrillation who have coronary artery disease without ongoing ischemia.
-
Using Riluzole to Reduce Atrial Fibrillation Episodes
This study is testing if the medication Riluzole can help reduce episodes of irregular heartbeats in adults with paroxysmal atrial fibrillation compared to a placebo.
-
Screening and treating sleep apnea in people with atrial fibrillation who are candidates for ablation
This program will try screening for and treating sleep apnea in adults with atrial fibrillation that persists despite medication to see if treating sleep apnea lowers arrhythmia burden and reduces the need for ablation.
Related topics
Quick answers
How many Atrial Fibrillation (Paroxysmal) clinical trials are recruiting right now?
15, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (4 trials), Czechia (3 trials), Italy (2 trials), Spain (2 trials), Greece (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.